financetom
Business
financetom
/
Business
/
Silicon Valley Bank's former parent can pursue $1.93 billion FDIC lawsuit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Silicon Valley Bank's former parent can pursue $1.93 billion FDIC lawsuit
Feb 28, 2025 8:14 AM

Feb 28 (Reuters) - Silicon Valley Bank's former parent

may pursue a lawsuit to recover $1.93 billion of deposits that

the Federal Deposit Insurance Corp seized following the bank's

March 2023 collapse, a federal judge ruled.

In a decision on Thursday, U.S. District Judge Beth Labson

Freeman in San Jose, California said the former parent, now

known as SVB Financial Trust, adequately alleged that the FDIC

in its corporate capacity maintained control over the deposits,

though the allegations were "vanishingly thin."

The agency had argued that the deposits were controlled by

the FDIC in its capacity as Silicon Valley Bank's receiver, a

different legal entity that the former parent is also suing.

Freeman also said the former parent can try to show it

properly relied on FDIC assurances that deposits would remain

safe, inducing it to leave them alone. She dismissed a due

process claim.

Lawyers for the FDIC and the former parent did not

immediately respond to requests for comment on Friday.

Silicon Valley Bank collapsed after rising interest rates

caused big losses in its portfolio of long-term government bonds

and mortgage-backed securities.

Its problems sparked a bank run, in part because an

unusually large percentage of deposits was uninsured, and

disrupted many technology startups whose deposits it held.

The bank had about $209 billion of assets before it failed,

in one of the largest collapses in U.S. banking history.

Much of its business was transferred to First Citizens

BancShares, a North Carolina lender.

Freeman ruled six weeks after the FDIC sued 17 former

Silicon Valley Bank executives and directors, including onetime

Chief Executive Gregory Becker, to recover billions of dollars

for alleged gross negligence and breaches of fiduciary duty.

"SVB represents a case of egregious mismanagement of

interest-rate and liquidity risks," the FDIC said last month.

The case is SVB Financial Trust v FDIC, U.S. District Court,

Northern District of California, No. 23-06543.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rocket Lab Insider Sold Shares Worth $41,985,316, According to a Recent SEC Filing
Rocket Lab Insider Sold Shares Worth $41,985,316, According to a Recent SEC Filing
Sep 23, 2025
03:38 AM EDT, 09/23/2025 (MT Newswires) -- Adam C. Spice, Chief Financial Officer, on September 18, 2025, sold 874,588 shares in Rocket Lab ( RKLB ) for $41,985,316. Following the Form 4 filing with the SEC, Spice has control over a total of 2,057,889 common shares of the company, with 2,057,889 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1819994/000200101125000080/xslF345X05/edgardoc.xml ...
AvePoint Insider Sold Shares Worth $3,285,360, According to a Recent SEC Filing
AvePoint Insider Sold Shares Worth $3,285,360, According to a Recent SEC Filing
Sep 23, 2025
03:42 AM EDT, 09/23/2025 (MT Newswires) -- James Caci, Chief Financial Officer, on September 18, 2025, sold 216,000 shares in AvePoint ( AVPT ) for $3,285,360. Following the Form 4 filing with the SEC, Caci has control over a total of 213,030 common shares of the company, with 213,030 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1777921/000143774925029637/xslF345X05/rdgdoc.xml ...
EXPLAINER-Why is leucovorin being considered as an autism treatment?
EXPLAINER-Why is leucovorin being considered as an autism treatment?
Sep 23, 2025
(Adds detail about GSK in paragraph 3) By Nancy Lapid Sept 23 (Reuters) - On Monday, the U.S. Food and Drug Administration published a notice to the Federal Register ahead of a speech by President Donald Trump, approving a version of leucovorin made by GlaxoSmithKline that the company had previously withdrawn from the FDA's consideration when it stopped manufacturing the...
AvePoint Insider Sold Shares Worth $31,468,973, According to a Recent SEC Filing
AvePoint Insider Sold Shares Worth $31,468,973, According to a Recent SEC Filing
Sep 23, 2025
03:43 AM EDT, 09/23/2025 (MT Newswires) -- Tianyi Jiang, Director, Chief Executive Officer, on September 18, 2025, sold 2,068,966 shares in AvePoint ( AVPT ) for $31,468,973. Following the Form 4 filing with the SEC, Jiang has control over a total of 13,841,853 common shares of the company, with 13,841,853 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1777921/000143774925029638/xslF345X05/rdgdoc.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved